Skip to main content
TipRanks
Go Ultimate75% OFF

Arbutus Biopharma (0SGC) Ownership - Who Owns Arbutus Biopharma?

1 Followers

Arbutus Biopharma (0SGC) Ownership Overview

  • 19.68% Insiders
  • 12.34% Mutual Funds
  • 28.01% Other Institutional Investors
  • 14.39% ETFs
  • 25.57% Public Companies and Individual Investors

The ownership structure of Arbutus Biopharma (GB:0SGC) stock is a mix of institutional, retail, and individual investors. Approximately 54.75% of the company’s stock is owned by Institutional Investors, 19.68% is owned by Insiders, and 25.57% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Entrypoint Capital, Llc$363,669
Dec 31, 2025Saba Capital Management$1,673,326
Dec 31, 2025Woodline Partners Lp$10,517,319

Top Shareholders

GB:0SGC top shareholders
Holder# of SharesType% HoldingValue
Roivant Sciences Ltd.29,880,079Insider19.49%99,142,102
BlackRock, Inc.14,515,428Institution9.47%48,162,190
Ishares8,329,711Institution5.43%27,637,981
Vanguard Index Funds6,829,678Institution4.46%22,660,872
Vanguard6,023,848Institution3.93%19,987,128
Spdr4,112,904Institution2.68%13,646,615
Morgan Stanley Insight Fund2,728,775Institution1.78%9,054,075
Michael Rockefeller2,281,856Institution1.49%7,571,198
Morgan Stanley Institutional Fund Inc1,978,273Institution1.29%6,563,910
Fidelity Salem Street Trust1,933,959Institution1.26%6,416,876

Top Mutual Fund Holders

GB:0SGC top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds6,829,678Institution4.46%22,660,872
Morgan Stanley Insight Fund2,728,775Institution1.78%9,054,075
Morgan Stanley Institutional Fund Inc1,978,273Institution1.29%6,563,910
Fidelity Salem Street Trust1,933,959Institution1.26%6,416,876
Fidelity Concord Street Trust1,585,423Institution1.03%5,260,434
Vanguard Scottsdale Funds1,110,321Institution0.72%3,684,045
Tiaa-cref Funds511,796Institution0.33%1,698,139
Schwab Capital Trust489,116Institution0.32%1,622,887
Vanguard World Fund435,449Institution0.28%1,444,820
Goldman Sachs Trust385,130Institution0.25%1,277,861

FAQ

Who Owns Arbutus Biopharma (GB:0SGC)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 54.75% of the company's stock is held by institutional investors, 19.68% is held by insiders, and 25.57% is held by public companies and individual investors.
What percentage of Arbutus Biopharma (GB:0SGC) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 54.75% of Arbutus Biopharma (GB:0SGC) stock is held by institutional investors: 12.34% by mutual funds, 14.39% by ETFs and 28.01% by other institutional investors.
What percentage of Arbutus Biopharma (GB:0SGC) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 25.57% of Arbutus Biopharma (GB:0SGC) stock is held by public companies and individual investors.
Who owns the most shares of Arbutus Biopharma (GB:0SGC)?
Roivant Sciences Ltd. owns the most shares of Arbutus Biopharma (GB:0SGC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.